Literature DB >> 6863501

Agar microdroplet assay for delayed hypersensitivity to Legionella pneumophila serogroup 1.

R Widen, T Klein, I Lee, H Friedman.   

Abstract

An agarose microdroplet technique was utilized to assess the cellular immunity of guinea pig lymphoid cells to Legionella pneumophila antigen in vitro. Both direct and indirect migration inhibition procedures were shown to be capable of detecting sensitization of guinea pigs to L. pneumophila antigens. Animals injected with adjuvant alone or unrelated antigens did not yield spleen cells responsive to L. pneumophila, indicating the specificity of the response. Migration inhibition factor induction by Legionella antigen in vitro correlated well with skin test responses in vivo. The positive reaction detected by migration inhibition occurred at times similar to that of skin reactivity but later than that of the earliest serum antibody titers. The assay appears to be useful for monitoring sensitization to Legionella and may be applicable to the study of cell-mediated immunity to this bacterium in infected individuals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863501      PMCID: PMC272747          DOI: 10.1128/jcm.17.5.819-823.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  In vitro interaction between normal cynolmolgus monkey alveolar macrophages and Legionnaires disease bacteria.

Authors:  R A Kishimoto; M D Kastello; J D White; F G Shirey; V G McGann; E W Larson; K W Hedlund
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

2.  Detection of Legionnaires disease bacteria by direct immunofluorescent staining.

Authors:  W B Cherry; B Pittman; P P Harris; G A Hebert; B M Thomason; L Thacker; R E Weaver
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

3.  The pathology of Legionnaires' disease. Fourteen fatal cases from the 1977 outbreak in Vermont.

Authors:  W C Winn; F L Glavin; D P Perl; J L Keller; T L Andres; T M Brown; C M Coffin; J E Sensecqua; L N Roman; J E Craighead
Journal:  Arch Pathol Lab Med       Date:  1978-07       Impact factor: 5.534

4.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

5.  Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test.

Authors:  G C Klein; W L Jones; J C Feeley
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

6.  Development of a chemically defined liquid medium for growth of Legionella pneumophila.

Authors:  L Pine; J R George; M W Reeves; W K Harrell
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

7.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

8.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  Direct immunofluorescent detection of Legionella pneumophila in respiratory specimens.

Authors:  W C Winn; W B Cherry; R O Frank; C A Casey; C V Broome
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

10.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

View more
  1 in total

1.  Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro.

Authors:  H Friedman; R Widen; I Lee; T Klein
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.